WASHINGTON (AP) - A panel of U.S. respiratory experts has voted in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravence for treating chronic lung disease.
A majority of Food and Drug Administration panelists voted that the Breo Ellipta inhaler is safe and effective for long-term use and to control flare ups in patients with chronic obstructive pulmonary disorder.
The FDA is not required to follow the group's recommendation, though it often does.
The ailment, often called smoker's cough, can cause a number of breathing problems, including chronic bronchitis and emphysema.
Breo is a combination of two respiratory drugs that help to open lung airways and reduce swelling. The combination drug is designed to be used with the Ellipta inhaler device.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Buffalo Police have arrested 26-year-old Nicholas Finnegan of South Buffalo and charged him with pushing Russ Ross to his death.
Police say there were 32 burglaries, 20 in Albion, five in Medina, four in Oakfield and three in the City of Lockport.
A seven-year-old Buffalo girl got dropped off more than three miles away from the bus stop where her mother was waiting for her on Wednesday.
Police, FBI agents and a bomb squad all showed up on a quiet residential street in North Buffalo overnight.
The Niagara County Sheriff's is on the scene of a suspected meth lab in Sanborn.
Authorities say they're investigating the deaths of two inmates at New York's maximum-security Attica Correctional Facility.